Extraction, purification and radioiodination of Khellin as cancer theranostic agent
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 178, 109970
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Khellin and Visnagin Differentially Modulate AHR Signaling and Downstream CYP1A Activity in Human Liver CellsPLOS ONE, 2013
- 99mTc–meropenem as a potential SPECT imaging probe for tumor hypoxiaJournal of Radioanalytical and Nuclear Chemistry, 2011
- Preparation of 125I-celecoxib with high purity as a possible tumor agentJournal of Radioanalytical and Nuclear Chemistry, 2010
- Declaration of Helsinki, 2008Journal of Postgraduate Medicine, 2009
- Reactions of 7-polyfluoroalkylnorkhellins with alkyl mercaptoacetates: a simple synthesis of dihydrothienopsoralens and benzofuran derivatives of 2-oxa-7-thiabicyclo[3.2.1]octaneTetrahedron Letters, 2001
- The Involvement of a Ca2+Channel Blocking Mode of Action in the Pharmacology ofAmmi visnagaFruits1Planta Medica, 1994
- Simultaneous TLC Separation of Khellin and Visnagin and Their Assay in Ammi visnaga Fruits, Extracts, and FormulationsJournal of Pharmaceutical Sciences, 1970
- Visnagin: Biosynthesis and Isolation fromAmmi visnagiSuspension CulturesScience, 1965
- Experiments with KhellinJournal of the American Pharmaceutical Association (Scientific ed.), 1952
- Khellin. Part II. Methods for the determination of two principles isolated from Ammi visnaga lam * *Presented to the Pharmacy Subsection of the American Association for the Advancement of Science, Cleveland meeting, December 28, 1950. †Journal of the American Pharmaceutical Association (Scientific ed.), 1951